Bears Are Losing Control Over OrthoPediatrics (KIDS), Here's Why It's a 'Buy' Now
Shareholders in OrthoPediatrics (NASDAQ:KIDS) Have Lost 58%, as Stock Drops 7.6% This Past Week
Express News | JMP Securities Reiterates Market Outperform on OrthoPediatrics, Maintains $50 Price Target
Truist Financial Maintains OrthoPediatrics(KIDS.US) With Hold Rating, Announces Target Price $34
Stifel Maintains OrthoPediatrics(KIDS.US) With Buy Rating, Maintains Target Price $40
A Quick Look at Today's Ratings for OrthoPediatrics(KIDS.US), With a Forecast Between $34 to $50
OrthoPediatrics (KIDS) Initiated With a Hold at Truist Financial
Buy Rating Reaffirmed for OrthoPediatrics on Robust Growth Strategy and Strong Financials
Express News | OrthoPediatrics Corp : Truist Securities Raises Target Price to $34 From $30
OrthoPediatrics Showcases Growth and Outlook in Investor Presentations
OrthoPediatrics Corp. Announces Launch of Enabling Technologies Division
BTIG Maintains OrthoPediatrics(KIDS.US) With Buy Rating, Maintains Target Price $44
Piper Sandler Maintains OrthoPediatrics(KIDS.US) With Buy Rating, Raises Target Price to $44
Piper Sandler Reaffirms Their Buy Rating on OrthoPediatrics (KIDS)
Wall Street Analysts Predict a 31.2% Upside in OrthoPediatrics (KIDS): Here's What You Should Know
Orthopediatrics Insider Sold Shares Worth $293,000, According to a Recent SEC Filing
OrthoPediatrics Corp. to Host Investor Day on September 12, 2024
Express News | Needham Reiterates Buy on OrthoPediatrics, Maintains $42 Price Target
OrthoPediatrics Analyst Ratings
OrthoPediatrics Enhances Investor Relations With Strategic Presentations